• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黎巴嫩2至10岁儿童脂质紊乱的通用筛查计划:一种新方法。

Universal screening program for lipid disorders in 2-10 years old Lebanese children: A new approach.

作者信息

Georges Nicolas, Simon Akiki, Naim Bassil, Georges Nawfal, Georges Abi Fares, Tanios Akiki

机构信息

Holy Spirit University of Kaslik, Faculty of Medicine and Medical Sciences, Pediatric Department, Division of Endocrinology Centre Hospitalier Universitaire Notre Dame des Secours, Byblos, Jbeil, Lebanon.

出版信息

Int J Pediatr Adolesc Med. 2019 Sep;6(3):101-108. doi: 10.1016/j.ijpam.2019.05.003. Epub 2019 May 31.

DOI:10.1016/j.ijpam.2019.05.003
PMID:31700968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6824154/
Abstract

INTRODUCTION

Dyslipidemia has been recognized as a risk factor for cardiovascular diseases. Studies have showed that the development of atherosclerotic lesions begins in childhood and progresses throughout life. While the prevalence of dyslipidemia in adults has been reported to be 10 times higher in Lebanon compared to Western countries, data on the prevalence of dyslipidemic children in Lebanon is lacking.

OBJECTIVES

This study was conducted to assess the benefit of a protocol for universal screening for lipid disorders in Lebanese children aged between two and ten years old.

MATERIALS AND METHODS

A total of four hundred children aged 2-10 years old (51.5% boys) were included in the study. The subjects were recruited from private pediatric clinics after parental consent. Fasting total cholesterol (TC), triglycerides (TG), low density lipoprotein (LDL), high density lipoprotein (HDL) levels were measured and non-HDL cholesterol was calculated. The values were categorized according to 2011 Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents.

RESULTS

The overall prevalence of high TC (≥200 mg/dL), high non-HDL-C (≥145 mg/dL), high LDL (≥130 mg/dL), high TG (≥100 mg/dL) and low HDL (<40 mg/dL) was respectively 19.5%, 23%, 19%, 31.8% and 20%. The overall frequency of dyslipidemia was 51.7%. In a bivariate analysis, dyslipidemia in children was associated with a BMI ≥95th percentile and parents having TC > 240 mg/dL with a P value respectively of .006 and .0001. Furthermore, high TG was independently associated with a BMI ≥95th percentile ( = .0001). Children with parents having TC > 240 mg/dL was significantly correlated with high TC, high non-HDL-C and high LDL ( = .0001 for all variables). Finally, according to the Pediatric Dyslipidemia Screening Guidelines from the 2011 Expert Panel, 62.3% of dyslipidemic children had at least 1 risk factor that qualified them for screening while 37.7% of them didn't have any risk factor.

CONCLUSIONS

It is preferable to review the latest pediatric dyslipidemia screening guidelines by performing a universal screening program since a third of our dyslipidemic Lebanese children will be missed.

摘要

引言

血脂异常已被公认为心血管疾病的一个危险因素。研究表明,动脉粥样硬化病变始于儿童期,并在一生中不断发展。虽然据报道黎巴嫩成年人血脂异常的患病率比西方国家高10倍,但黎巴嫩血脂异常儿童的患病率数据却很缺乏。

目的

本研究旨在评估一项针对2至10岁黎巴嫩儿童进行血脂异常普遍筛查方案的益处。

材料与方法

共有400名2至10岁的儿童(51.5%为男孩)纳入本研究。经家长同意后,从私立儿科诊所招募受试者。测量空腹总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)水平,并计算非HDL胆固醇。根据2011年儿童和青少年心血管健康与风险降低综合指南专家小组的标准对这些值进行分类。

结果

高TC(≥200mg/dL)、高非HDL-C(≥145mg/dL)、高LDL(≥130mg/dL)、高TG(≥100mg/dL)和低HDL(<40mg/dL)的总体患病率分别为19.5%、23%、19%、31.8%和20%。血脂异常的总体发生率为51.7%。在双变量分析中,儿童血脂异常与BMI≥第95百分位数以及父母TC>240mg/dL相关,P值分别为0.006和0.0001。此外,高TG与BMI≥第95百分位数独立相关(P = 0.0001)。父母TC>240mg/dL的儿童与高TC、高非HDL-C和高LDL显著相关(所有变量的P = 0.0001)。最后,根据2011年专家小组的儿童血脂异常筛查指南,62.3%的血脂异常儿童至少有1个符合筛查条件的危险因素,而37.7%的儿童没有任何危险因素。

结论

由于三分之一的黎巴嫩血脂异常儿童将会被漏筛,因此通过开展普遍筛查计划来重新审视最新的儿童血脂异常筛查指南是可取的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/6824154/a53364434408/egi1084DVLJ4ML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/6824154/1fed2b01c306/egi10782CJHVQS.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/6824154/6be6d7b05004/egi103XDZMD22S.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/6824154/a53364434408/egi1084DVLJ4ML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/6824154/1fed2b01c306/egi10782CJHVQS.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/6824154/6be6d7b05004/egi103XDZMD22S.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/6824154/a53364434408/egi1084DVLJ4ML.jpg

相似文献

1
Universal screening program for lipid disorders in 2-10 years old Lebanese children: A new approach.黎巴嫩2至10岁儿童脂质紊乱的通用筛查计划:一种新方法。
Int J Pediatr Adolesc Med. 2019 Sep;6(3):101-108. doi: 10.1016/j.ijpam.2019.05.003. Epub 2019 May 31.
2
Pediatric Dyslipidemia小儿血脂异常
3
4
Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.土耳其成年人血脂异常及相关危险因素的患病率:特拉布宗血脂研究
Endocrine. 2008 Aug-Dec;34(1-3):36-51. doi: 10.1007/s12020-008-9100-z. Epub 2008 Nov 12.
5
Circulating PCSK9 Linked to Dyslipidemia in Lebanese Schoolchildren.黎巴嫩学童中循环血中前蛋白转化酶枯草溶菌素9与血脂异常有关。
Metabolites. 2022 May 31;12(6):504. doi: 10.3390/metabo12060504.
6
The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.非高密度脂蛋白在管理5期慢性肾脏病血脂异常中的作用
Clin Nephrol. 2006 Nov;66(5):336-47. doi: 10.5414/cnp66336.
7
Longitudinal changes of lipid profile in the Lebanese pediatric population.黎巴嫩儿科人群血脂谱的纵向变化。
Lipids Health Dis. 2019 Feb 11;18(1):48. doi: 10.1186/s12944-019-0991-x.
8
Distinct Lipoprotein Curves in Normal Weight, Overweight, and Obese Children and Adolescents.正常体重、超重及肥胖儿童和青少年的不同脂蛋白曲线
J Pediatr Gastroenterol Nutr. 2017 Dec;65(6):673-680. doi: 10.1097/MPG.0000000000001674.
9
Lipid profile and dyslipidemia among school-age children in urban Ghana.加纳城市学龄儿童的血脂状况和血脂异常。
BMC Public Health. 2018 Mar 6;18(1):320. doi: 10.1186/s12889-018-5196-0.
10

引用本文的文献

1
Circulating PCSK9 Linked to Dyslipidemia in Lebanese Schoolchildren.黎巴嫩学童中循环血中前蛋白转化酶枯草溶菌素9与血脂异常有关。
Metabolites. 2022 May 31;12(6):504. doi: 10.3390/metabo12060504.
2
Nanomedicine of Plant Origin for the Treatment of Metabolic Disorders.用于治疗代谢紊乱的植物源纳米医学
Front Bioeng Biotechnol. 2022 Feb 11;9:811917. doi: 10.3389/fbioe.2021.811917. eCollection 2021.
3
Universal Lipid Screening Among 9- to 11-Year-Old Children: Screening Results and Physician Management.9 至 11 岁儿童的普遍血脂筛查:筛查结果和医生管理。

本文引用的文献

1
Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.估计杂合子家族性高胆固醇血症的患病率:一项系统评价和荟萃分析。
BMJ Open. 2017 Sep 1;7(9):e016461. doi: 10.1136/bmjopen-2017-016461.
2
Statins in the Management of Pediatric Dyslipidemia.他汀类药物在儿童血脂异常管理中的应用
J Pediatr Nurs. 2016 Nov-Dec;31(6):723-735. doi: 10.1016/j.pedn.2016.07.004. Epub 2016 Aug 3.
3
Distribution and correlates of non-high-density lipoprotein cholesterol and triglycerides in Lebanese school children.
Clin Pediatr (Phila). 2022 Mar;61(3):280-288. doi: 10.1177/00099228221075409. Epub 2022 Jan 28.
4
Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review.用于预防代谢综合征的纳米植物药:药理学与生物制药学综述
Front Bioeng Biotechnol. 2020 May 14;8:425. doi: 10.3389/fbioe.2020.00425. eCollection 2020.
5
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care.家族性高胆固醇血症:设计适应性护理模式的知识演进。
Nat Rev Cardiol. 2020 Jun;17(6):360-377. doi: 10.1038/s41569-019-0325-8. Epub 2020 Jan 23.
黎巴嫩学龄儿童中非高密度脂蛋白胆固醇和甘油三酯的分布及其相关因素
J Clin Lipidol. 2016 Mar-Apr;10(2):378-85. doi: 10.1016/j.jacl.2015.12.018. Epub 2016 Jan 6.
4
Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES).1999 年至 2012 年美国国家健康和营养调查(NHANES)中家族性高胆固醇血症的流行情况。
Circulation. 2016 Mar 15;133(11):1067-72. doi: 10.1161/CIRCULATIONAHA.115.018791.
5
Universal cholesterol screening of children in community-based ambulatory pediatric clinics.在社区门诊儿科诊所对儿童进行普遍的胆固醇筛查。
J Clin Lipidol. 2015 Sep-Oct;9(5 Suppl):S88-92. doi: 10.1016/j.jacl.2015.05.006. Epub 2015 May 27.
6
The epidemiology of cardiovascular disease in the UK 2014.2014年英国心血管疾病流行病学
Heart. 2015 Aug;101(15):1182-9. doi: 10.1136/heartjnl-2015-307516. Epub 2015 Jun 3.
7
Serum lipid levels and dyslipidaemia prevalence among 2-10 year-old Northern Mexican children.墨西哥北部2至10岁儿童的血脂水平及血脂异常患病率
PLoS One. 2015 Mar 20;10(3):e0119877. doi: 10.1371/journal.pone.0119877. eCollection 2015.
8
Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.儿童和青少年心血管健康与风险降低综合指南专家小组:总结报告
Pediatrics. 2011 Dec;128 Suppl 5(Suppl 5):S213-56. doi: 10.1542/peds.2009-2107C. Epub 2011 Nov 14.
9
Lipid management in children.儿童脂质管理
Endocrinol Metab Clin North Am. 2009 Mar;38(1):171-83. doi: 10.1016/j.ecl.2008.11.006.
10
Lipid screening and cardiovascular health in childhood.儿童期血脂筛查与心血管健康
Pediatrics. 2008 Jul;122(1):198-208. doi: 10.1542/peds.2008-1349.